111, Inc. Sponsored ADR (NASDAQ:YI - Get Free Report) Director Yang Luke Chen sold 44,000 shares of the business's stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $0.23, for a total transaction of $10,120.00. Following the completion of the sale, the director owned 495,462 shares of the company's stock, valued at approximately $113,956.26. The trade was a 8.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Yang Luke Chen also recently made the following trade(s):
- On Friday, June 12th, Yang Luke Chen sold 49,920 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $11,481.60.
- On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The stock was sold at an average price of $0.25, for a total value of $850.00.
- On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $388.80.
111 Price Performance
NASDAQ:YI opened at $4.45 on Wednesday. The firm has a 50-day moving average of $5.84 and a two-hundred day moving average of $5.67. The stock has a market cap of $39.09 million, a P/E ratio of -3.18 and a beta of 0.60. 111, Inc. Sponsored ADR has a 1-year low of $2.48 and a 1-year high of $11.17.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings downgraded 111 from a "sell (d-)" rating to a "sell (e+)" rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, 111 has an average rating of "Sell".
View Our Latest Research Report on YI
111 Company Profile
(
Get Free Report)
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc's product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
